TMEM家族在肿瘤中的研究进展
Research Progress of TMEM Family in Tumour
DOI: 10.12677/wjcr.2025.151003, PDF,   
作者: 谢 珣, 陈 勇, 黎 清, 宁思艺, 向 翼:长沙市口腔医院检验病理科,湖南 长沙
关键词: TMEM蛋白生物标志物肿瘤TMEM Protein Biomarker Tumour
摘要: TMEM (Transmembrane, TMEM)是一类整合性膜蛋白,其特点在于能够跨越整个脂质双分子层并永久地锚定其中,分布在线粒体、内质网、溶酶体以及高尔基体等细胞器的细胞膜上。在恶性肿瘤的形成、发展和扩散等关键生物学过程中,TMEM家族蛋白扮演着举足轻重的角色。这些蛋白质的作用不仅局限于肿瘤细胞的增殖、侵袭和迁移,而且还显示出成为新型肿瘤生物标记物和治疗目标的巨大潜力。本文将对TMEM蛋白在恶性肿瘤研究领域内的最新进展进行回顾和分析。
Abstract: TMEM (Transmembrane, TMEM) is a class of integrated membrane proteins that span and permanently anchor the entire lipid bilayer and are distributed on the cell membranes of organelles such as mitochondria, endoplasmic reticulum, lysosomes and Golgi apparatus. TMEM family proteins play an important role in the formation, development and spread of malignant tumors. The role of these proteins is not limited to the proliferation, invasion and migration of tumor cells, but also shows great potential as novel tumor biomarkers and therapeutic targets. This article will review and analyze the latest progress of TMEM protein in the field of malignant tumor research.
文章引用:谢珣, 陈勇, 黎清, 宁思艺, 向翼. TMEM家族在肿瘤中的研究进展[J]. 世界肿瘤研究, 2025, 15(1): 16-23. https://doi.org/10.12677/wjcr.2025.151003

参考文献

[1] Feng, R., Zong, Y., Cao, S. and Xu, R. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statistics? Cancer Communications, 39, 1-12. [Google Scholar] [CrossRef] [PubMed]
[2] Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef] [PubMed]
[3] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] Jiang, X., Wang, L., Liu, Z., Song, W., Zhou, M. and Xi, L. (2020) TMEM48 Promotes Cell Proliferation and Invasion in Cervical Cancer via Activation of the Wnt/β-Catenin Pathway. Journal of Receptors and Signal Transduction, 41, 371-377. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, J., Su, Z., Ding, Q., Shen, L., Nie, X., Pan, X., et al. (2019) Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 27, 819-826. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, X., Li, X., Xu, S., Hu, S., Wang, T., Li, R., et al. (2023) TMEM11 Regulates Cardiomyocyte Proliferation and Cardiac Repair via Mettl1-Mediated m7G Methylation of ATF5 mRNA. Cell Death & Differentiation, 30, 1786-1798. [Google Scholar] [CrossRef] [PubMed]
[7] Ehrlich, K.C., Lacey, M. and Ehrlich, M. (2020) Epigenetics of Skeletal Muscle-Associated Genes in the ASB, LRRC, TMEM, and OSBPL Gene Families. Epigenomes, 4, Article 1. [Google Scholar] [CrossRef] [PubMed]
[8] Deng, H., Li, T., Wei, F., Han, W., Xu, X. and Zhang, Y. (2023) High Expression of TMEM200A Is Associated with a Poor Prognosis and Immune Infiltration in Gastric Cancer. Pathology and Oncology Research, 29, Article 1610893. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, S., Dai, H., Li, W., Wang, R., Wu, H., Shen, M., et al. (2021) TMEM116 Is Required for Lung Cancer Cell Motility and Metastasis through PDK1 Signaling Pathway. Cell Death & Disease, 12, Article No. 1086. [Google Scholar] [CrossRef] [PubMed]
[10] Zhuang, J., Huang, Y., Zheng, W., Yang, S., Zhu, G., Wang, J., et al. (2019) TMEM100 Expression Suppresses Metastasis and Enhances Sensitivity to Chemotherapy in Gastric Cancer. Biological Chemistry, 401, 285-296. [Google Scholar] [CrossRef] [PubMed]
[11] Levental, I. and Lyman, E. (2022) Regulation of Membrane Protein Structure and Function by Their Lipid Nano-Environment. Nature Reviews Molecular Cell Biology, 24, 107-122. [Google Scholar] [CrossRef] [PubMed]
[12] Babcock, J.J. and Li, M. (2013) Deorphanizing the Human Transmembrane Genome: A Landscape of Uncharacterized Membrane Proteins. Acta Pharmacologica Sinica, 35, 11-23. [Google Scholar] [CrossRef] [PubMed]
[13] Smith, S.M. (2016) Strategies for the Purification of Membrane Proteins. In: Walls, D. and Loughran, S., Eds., Protein Chromatography, Springer, 389-400. [Google Scholar] [CrossRef] [PubMed]
[14] Herrera-Quiterio, G.A. and Encarnación-Guevara, S. (2023) The Transmembrane Proteins (TMEM) and Their Role in Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition in Cancer. Frontiers in Oncology, 13, Article 1244740. [Google Scholar] [CrossRef] [PubMed]
[15] Vinothkumar, K.R. and Henderson, R. (2010) Structures of Membrane Proteins. Quarterly Reviews of Biophysics, 43, 65-158. [Google Scholar] [CrossRef] [PubMed]
[16] Roterman, I., Stapor, K. and Konieczny, L. (2022) The Contribution of Hydrophobic Interactions to Conformational Changes of Inward/outward Transmembrane Transport Proteins. Membranes, 12, Article 1212. [Google Scholar] [CrossRef] [PubMed]
[17] Marx, S., Dal Maso, T., Chen, J., Bury, M., Wouters, J., Michiels, C., et al. (2020) Transmembrane (TMEM) Protein Family Members: Poorly Characterized Even If Essential for the Metastatic Process. Seminars in Cancer Biology, 60, 96-106. [Google Scholar] [CrossRef] [PubMed]
[18] Hegde, R.S. (2022) The Function, Structure, and Origins of the ER Membrane Protein Complex. Annual Review of Biochemistry, 91, 651-678. [Google Scholar] [CrossRef] [PubMed]
[19] Lei, H., Fang, F., Yang, C., Chen, X., Li, Q. and Shen, X. (2024) Lifting the Veils on Transmembrane Proteins: Potential Anticancer Targets. European Journal of Pharmacology, 963, Article 176225. [Google Scholar] [CrossRef] [PubMed]
[20] Li, L. and Li, J. (2023) Dimerization of Transmembrane Proteins in Cancer Immunotherapy. Membranes, 13, Article 393. [Google Scholar] [CrossRef] [PubMed]
[21] Beasley, H.K., Rodman, T.A., Collins, G.V., Hinton, A. and Exil, V. (2021) TMEM135 Is a Novel Regulator of Mitochondrial Dynamics and Physiology with Implications for Human Health Conditions. Cells, 10, Article 1750. [Google Scholar] [CrossRef] [PubMed]
[22] Li, Q., Huo, A., Li, M., Wang, J., Yin, Q., Chen, L., et al. (2024) Structure, Ligands, and Roles of GPR126/ADGRG6 in the Development and Diseases. Genes & Diseases, 11, 294-305. [Google Scholar] [CrossRef] [PubMed]
[23] Moretti, F., Bergman, P., Dodgson, S., Marcellin, D., Claerr, I., Goodwin, J.M., et al. (2018) TMEM41B Is a Novel Regulator of Autophagy and Lipid Mobilization. EMBO reports, 19, e45889. [Google Scholar] [CrossRef] [PubMed]
[24] Ennishi, D., Healy, S., Bashashati, A., Saberi, S., Hother, C., Mottok, A., et al. (2020) TMEM30A Loss-of-Function Mutations Drive Lymphomagenesis and Confer Therapeutically Exploitable Vulnerability in B-Cell Lymphoma. Nature Medicine, 26, 577-588. [Google Scholar] [CrossRef] [PubMed]
[25] Durin, Z., Houdou, M., Morelle, W., Barré, L., Layotte, A., Legrand, D., et al. (2022) Differential Effects of D-Galactose Supplementation on Golgi Glycosylation Defects in TMEM165 Deficiency. Frontiers in Cell and Developmental Biology, 10, Article 903953. [Google Scholar] [CrossRef] [PubMed]
[26] Ye, Y., Wang, M., Wang, B., et al. (2017) CD98, a Potential Diagnostic Cancer-Related Biomarker, and Its Prognostic Impact in Colorectal Cancer Patients. International Journal of Clinical and Experimental Pathology, 10, 5418-5429.
[27] Chen, J., Wang, D., Chen, H., Gu, J., Jiang, X., Han, F., et al. (2022) TMEM196 Inhibits Lung Cancer Metastasis by Regulating the Wnt/β-Catenin Signaling Pathway. Journal of Cancer Research and Clinical Oncology, 149, 653-667. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, J. and Zhu, H. (2018) TMEM106A Inhibits Cell Proliferation, Migration, and Induces Apoptosis of Lung Cancer Cells. Journal of Cellular Biochemistry, 120, 7825-7833. [Google Scholar] [CrossRef] [PubMed]
[29] Anzai, T. and Matsumura, Y. (2019) Topological Analysis of TMEM180, a Newly Identified Membrane Protein That Is Highly Expressed in Colorectal Cancer Cells. Biochemical and Biophysical Research Communications, 520, 566-572. [Google Scholar] [CrossRef] [PubMed]
[30] Mei, S., Ke, J., Tian, J., Ying, P., Yang, N., Wang, X., et al. (2019) A Functional Variant in the Boundary of a Topological Association Domain Is Associated with Pancreatic Cancer Risk. Molecular Carcinogenesis, 58, 1855-1862. [Google Scholar] [CrossRef] [PubMed]
[31] Stoffel, E.M. and Murphy, C.C. (2020) Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology, 158, 341-353. [Google Scholar] [CrossRef] [PubMed]
[32] Li, J., Ma, X., Chakravarti, D., Shalapour, S. and DePinho, R.A. (2021) Genetic and Biological Hallmarks of Colorectal Cancer. Genes & Development, 35, 787-820. [Google Scholar] [CrossRef] [PubMed]
[33] Dariya, B., Aliya, S., Merchant, N., Alam, A. and Nagaraju, G.P. (2020) Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches. Critical Reviews™ in Oncogenesis, 25, 71-94. [Google Scholar] [CrossRef] [PubMed]
[34] Raskov, H., Søby, J.H., Troelsen, J., Bojesen, R.D. and Gögenur, I. (2020) Driver Gene Mutations and Epigenetics in Colorectal Cancer. Annals of Surgery, 271, 75-85. [Google Scholar] [CrossRef] [PubMed]
[35] Zhu, Y. and Li, X. (2023) Advances of Wnt Signalling Pathway in Colorectal Cancer. Cells, 12, Article 447. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, J., Xiao, Q., Xiao, J., Niu, C., Li, Y., Zhang, X., et al. (2022) Wnt/β-Catenin Signalling: Function, Biological Mechanisms, and Therapeutic Opportunities. Signal Transduction and Targeted Therapy, 7, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[37] Hayat, R., Manzoor, M. and Hussain, A. (2022) Wnt Signaling Pathway: A Comprehensive Review. Cell Biology International, 46, 863-877. [Google Scholar] [CrossRef] [PubMed]
[38] Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., et al. (2022) Wnt Signaling in Colorectal Cancer: Pathogenic Role and Therapeutic Target. Molecular Cancer, 21, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
[39] Wang, Y., Jin, Q., Zhang, S. and Wang, Y. (2023) Overexpression of TMEM79 Combined with SMG5 Is Related to Prognosis, Tumor Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma. European Journal of Medical Research, 28, Article No. 490. [Google Scholar] [CrossRef] [PubMed]
[40] Huo, T., Canepa, R., Sura, A., Modave, F. and Gong, Y. (2017) Colorectal Cancer Stages Transcriptome Analysis. PLOS ONE, 12, e0188697. [Google Scholar] [CrossRef] [PubMed]
[41] Liu, L., Zhang, J., Li, S., Yin, L. and Tai, J. (2019) Silencing of TMEM158 Inhibits Tumorigenesis and Multidrug Resistance in Colorectal Cancer. Nutrition and Cancer, 72, 662-671. [Google Scholar] [CrossRef] [PubMed]
[42] Gao, D., Han, Y., Yang, Y., Herman, J.G., Linghu, E., Zhan, Q., et al. (2017) Methylation of TMEM176A Is an Independent Prognostic Marker and Is Involved in Human Colorectal Cancer Development. Epigenetics, 12, 575-583. [Google Scholar] [CrossRef] [PubMed]
[43] Li, H., Cheng, C., You, W., Zheng, J., Xu, J., Gao, P., et al. (2021) TMEM100 Modulates TGF-Β Signaling Pathway to Inhibit Colorectal Cancer Progression. Gastroenterology Research and Practice, 2021, Article 5552324. [Google Scholar] [CrossRef] [PubMed]
[44] Zhao, J., Zhu, D., Zhang, X., Zhang, Y., Zhou, J. and Dong, M. (2018) retracted: TMEM206 Promotes the Malignancy of Colorectal Cancer Cells by Interacting with AKT and Extracellular Signal‐Regulated Kinase Signaling Pathways. Journal of Cellular Physiology, 234, 10888-10898. [Google Scholar] [CrossRef] [PubMed]
[45] Shiraishi, T., Ikeda, K., Tsukada, Y., Nishizawa, Y., Sasaki, T., Ito, M., et al. (2021) High Expression of TMEM180, a Novel Tumour Marker, Is Associated with Poor Survival in Stage III Colorectal Cancer. BMC Cancer, 21, Article No. 302. [Google Scholar] [CrossRef] [PubMed]
[46] Anwanwan, D., Singh, S.K., Singh, S., Saikam, V. and Singh, R. (2020) Challenges in Liver Cancer and Possible Treatment Approaches. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1873, Article 188314. [Google Scholar] [CrossRef] [PubMed]
[47] Duan, J., Qian, Y., Fu, X., Chen, M., Liu, K., Liu, H., et al. (2021) TMEM106C Contributes to the Malignant Characteristics and Poor Prognosis of Hepatocellular Carcinoma. Aging, 13, 5585-5606. [Google Scholar] [CrossRef] [PubMed]
[48] Chen, D., Lou, Y., Lu, J., Fan, X., Zhu, Q. and Sun, H. (2023) Characterization of the Clinical Significance and Immunological Landscapes of a Novel TMEMs Signature in Hepatocellular Carcinoma and the Contribution of TMEM201 to Hepatocarcinogenesis. International Journal of Molecular Sciences, 24, Article 10285. [Google Scholar] [CrossRef] [PubMed]
[49] Shi, S., Wang, B., Wan, J., Song, L., Zhu, G., Du, J., et al. (2022) TMEM106A Transcriptionally Regulated by Promoter Methylation Is Involved in Invasion and Metastasis of Hepatocellular Carcinoma. Acta Biochimica et Biophysica Sinica, 54, 1008-1020. [Google Scholar] [CrossRef] [PubMed]
[50] Shen, K., Yu, W., Yu, Y., Liu, X. and Cui, X. (2018) Knockdown of TMEM45B Inhibits Cell Proliferation and Invasion in Gastric Cancer. Biomedicine & Pharmacotherapy, 104, 576-581. [Google Scholar] [CrossRef] [PubMed]
[51] Ao, X., Li, X., Chen, Y., Zang, Z., Guo, W. and Liang, J. (2020) TMEM98 mRNA Promotes Proliferation and Invasion of Gastric Cells by Directly Interacting with NF90 Protein. Cell Biology International, 44, 1820-1830. [Google Scholar] [CrossRef] [PubMed]
[52] Fang, F., Zhang, T., Lei, H. and Shen, X. (2023) TMEM200A Is a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer. PeerJ, 11, e15613. [Google Scholar] [CrossRef] [PubMed]
[53] Zhao, Y., Song, K., Zhang, Y., Xu, H., Zhang, X., Wang, L., et al. (2018) TMEM17 Promotes Malignant Progression of Breast Cancer via AKT/GSK3β Signaling. Cancer Management and Research, 10, 2419-2428. [Google Scholar] [CrossRef] [PubMed]
[54] Calo, C.A., Smith, B.Q., Dorayappan, K.D.P., Saini, U., Lightfoot, M., Wagner, V., et al. (2022) Aberrant Expression of TMEM205 Signaling Promotes Platinum Resistance in Ovarian Cancer: An Implication for the Antitumor Potential of DAP Compound. Gynecologic Oncology, 164, 136-145. [Google Scholar] [CrossRef] [PubMed]